It interacts with other peroxisome proliferator-activated receptor coactivators, and also with proteins involved in ribosome biogenesis (DKC1, NOL6 and NOP56), which are known to be associated with ribosomal dysfunction and increased cancer susceptibility in the human X-linked dyskeratosis congenital [86,87]. The gene discussed is NOP56; the disease is cancer.